News Daily News FDA Warns of Stroke and Arterial Dissection Risk With MS Drug L.A. McKeown November 29, 2018
News Conference News VIVA 2018 Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018
News Daily News Dabigatran Trials Come Up Short for Stroke of Unknown Cause and Cerebral Venous Thrombosis Todd Neale October 26, 2018
News Daily News Bariatric Surgery Reduces Hard CVD Events in Obese Patients With Type 2 Diabetes Michael O'Riordan October 18, 2018
News Industry News Thrombolytic Science Initiates Phase 2 Clinical Trial of its Novel Treatment Regimen for Ischemic Stroke September 05, 2018
News Conference News ESC 2018 ASCOT Legacy: Calcium Channel Blockers, Statins Confer Long-term Survival Benefits in Hypertensive Patients L.A. McKeown August 31, 2018
News Daily News Hospital Readmissions at 30 Days Declining for Stroke Patients Michael O'Riordan August 20, 2018
News Daily News In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check Caitlin E. Cox August 15, 2018
News Daily News Intracranial Hemorrhage Outside of A-fib: Different NOACs, Different Risks Todd Neale August 13, 2018
News Daily News New Review Probes Possibility of CVD Prevention Without Aspirin Michael O'Riordan July 04, 2018
News Daily News NSAIDs Account for Large Part of Osteoarthritis-CVD Link, Study Suggests Todd Neale June 21, 2018
News Conference News EuroPCR 2018 Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension Michael O'Riordan May 23, 2018
News Daily News Lower BP Targets Can Save Over 300,000 Lives a Year, Analysis Suggests L.A. McKeown May 23, 2018
News Daily News NAVIGATE ESUS: Rivaroxaban Fails to Prevent More Recurrent Cryptogenic Strokes Than Aspirin L.A. McKeown May 16, 2018
News Daily News Weighing of Female Sex in Stroke Risk Scores Needs Rethink in A-fib Todd Neale February 26, 2018
News Industry News New Real-World Analysis Finds Lower Risk of Major Bleeding and Similar Risk of Stroke with Standard Dose of Pradaxa® Compared to Rivaroxaban in NVAF Patients Newly Initiating Treatment January 29, 2018
News Conference News ISC 2018 COMPASS Analysis Explores Impact of Low-Dose Rivaroxaban Plus Aspirin on Stroke Todd Neale January 25, 2018